- Report
- April 2026
- 140 Pages
Global
From €2729EUR$2,999USD£2,330GBP
€3638EUR$3,999USD£3,107GBP
- Report
- February 2026
- 250 Pages
Global
From €4085EUR$4,490USD£3,489GBP
- Report
- June 2026
- 111 Pages
Global
From €4322EUR$4,750USD£3,691GBP
- Report
- June 2026
- 313 Pages
Global
From €2275EUR$2,500USD£1,943GBP
- Report
- July 2026
- 192 Pages
Global
From €3225EUR$3,545USD£2,755GBP
€3584EUR$3,939USD£3,061GBP
- Report
- December 2022
- 130 Pages
Global
From €5413EUR$5,950USD£4,623GBP
- Report
- January 2024
- 200 Pages
Global
From €3776EUR$4,150USD£3,225GBP
The Single Cell Multiomics market is a subset of the larger Genomics market. It focuses on the analysis of single cells, which can provide a more detailed understanding of the biological processes within a cell. This market is driven by the need to understand the complexity of biological systems, as well as the development of new technologies that enable the analysis of single cells.
Single Cell Multiomics technologies are used to analyze the transcriptome, epigenome, proteome, and metabolome of single cells. This allows researchers to gain a better understanding of the molecular mechanisms that underlie cellular processes. Additionally, Single Cell Multiomics can be used to identify biomarkers and to develop new therapeutic strategies.
Some companies in the Single Cell Multiomics market include 10x Genomics, Fluidigm, Bio-Rad, Illumina, and Thermo Fisher Scientific. Show Less Read more
